Prospective evaluation of factors influencing success rates of sentinel node biopsy in 814 breast cancer patients

Cancer Biotherapy and Radiopharmaceuticals

Volumn 19, Issue 6, 2004, Pages 784-790

  Schirrmeister, Holger ^a   Kotzerke, Jörg ^b   Vogl, Florian ^c   Buck, Andreas ^d   Czech, Norbert ^a   Koretz, Karin ^d   Helm, Gisela ^d   Kreienberg, Rolf ^d   Kühn, Thorsten ^e  

^a UNIVERSITY OF KIEL   (Germany)

^b DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

^c INSTITUTE FOR RENEWABLE ENERGY   (Italy)

^d UNIVERSITY OF ULM   (Germany)

^e Proj Grp for Interdisc Senology   (Germany)

Author keywords

Accuracy; Breast cancer; Multicenter study; Sentinel node

Indexed keywords

CYTOKERATIN; ISOSULFAN BLUE; NANOCOLL TC 99M;

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER STAGING; CLINICAL TRIAL; FEMALE; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PARTIAL MASTECTOMY; PATIENT SELECTION; PRIORITY JOURNAL; RELIABILITY; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY; STATISTICAL ANALYSIS;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPHATIC METASTASIS; LYMPHOGRAPHY; MIDDLE AGED; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; ROSANILINE DYES; SENTINEL LYMPH NODE BIOPSY; TECHNETIUM TC 99M SULFUR COLLOID;

EID: 14044257887     PISSN: 10849785     EISSN: None     Source Type: Journal    
DOI: 10.1089/cbr.2004.19.784     Document Type: Article

References (31)

1. Harris JR, Osteen RT. Patients with early breast cancer benefit from effective axillary treatment. Breast Cancer Res Treat 1985;5:17.
2. Avril N, Dose J, Jänicke F, et al. Assessment of axillary lymph node involvement in breast cancer patients with positron emission tomography using radiolabeled 2-(fluorine-18)-deoxy-2-fluoro D-glucose. J Natl Cancer Inst 1996;88:1204.
3. Schirrmeister H, Kühn T, Guhlmann A, et al. Fluorine-18 2-deoxy-2-fluoro-D-glucose PET in the preoperative staging of breast cancer: Comparison with the standard staging procedures. Eur J Nucl Med 2001;28:351.
4. Liljegren G, Holmberg L. Arm morbidity after sector resection and axillary dissection with or without post-operative radiotherapy in breast cancer. Stage I. Results from a randomised trial. Eur J Cancer 1997;33:193.
5. Hack TF, Cohen L, Katz J, et al. Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999;17:143.
6. Giuliano AE, Kirgan DM, Ross MI, et al. Lymphatic mapping and lymphadenectomy for breast cancer. Ann Surg 1994;220:391.
7. Krag D, Weaver D, Ashikaga T, et al. The sentinel node in breast cancer. New Engl J Med 1998;339:941.
8. Veronesi U, Paganelli G, Galimberti V, et al. Sentinel node biopsy to avoid axillary node dissection in breast cancer with clinically negative lymph nodes. Lancet 1997;349:1864.
9. McMasters K, Tuttle TM, Matthew DJD, et al. Sentinel lymph node biopsy for breast cancer: A suitable alternative to routine axillary dissection in multi-institutional practice when optimal technique is used. J Clin Oncol 2000;18:2560.
10. Giuliano AE, Jones RC, Brennan M, et al. Sentinel lymphadenectomy in breast cancer. J Clin Oncol 1997; 15:2345.
11. Rozenberg S, Liebens F, Ham H. The sentinel node in breast cancer: Acceptable false negative rate. Lancet 1999;353:1937.
12. Feldman SM, Krag DN, McNally RK, et al. Limitation in gamma probe localization of the sentinel node in breast cancer patients with large excisional biopsy. J Am Coll Surg 1999;188:248.
13. Cox CE, Pendas S, Cox JM, et al. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer. Ann Surg 1998:226.
14. McMasters KM, Wong SL, Marin RC, et al. Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer lymph node biopsy: Results of a multi-institutional study. Ann Surg 2001;193:601.
15. Kern KA. Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid. J Am Coll Surg 2001;193:601.
16. Borgstein PJ, Meijer S, Pijpers RJ, et al. Functional lymphatic anatomy for sentinel node biopsy in breast cancer: Echoes from the past and the periareolar blue method. Ann Surg 2000;88:608.
17. Roumen RMH, Geuskens LM, Valkenburg JGH. In search of the true sentinel node by different injection techniques in breast cancer patients. Eur J Surg Oncol 1999;25:347.
18. Veronesi U, Valagussa P. Inefficacy of internal mammary nodes dissection in breast cancer surgery. Cancer 1981;47:170.
19. Lacour J, Bucalossi P, Caceres E, et al. Radical mastectomy versus radical mastectomy plus internal mammary dissection. Five-year results of an international cooperative study. Cancer 1976;37:206.
20. Veronesi U, Cascellini N, Greco M, et al. Prognosis of breast cancer patients after mastectomy and dissection of the internal mammary nodes. Ann Surg 1985;202: 702.
21. Donegan WL. The influence of untreated internal mammary metastases upon the course of mammary cancer. Cancer 1977;39:533.
22. Noguchi M, Ohta N, Thomas M, et al. Risk of internal mammary lymph node metastases and itse prognostic value in breast cancer. J Surg Oncol 1993; 52:26.
23. Sugg SL, Ferguson DJ, Posner MC, et al. Should internal mammary nodes be sampled in the sentinel node area? Ann Surg Oncol 2000;7:188,
24. Qreene FA, Page DL, Flemming ID, et al. Cancer Staging Manual. New York: Springer-Verlag, 2002:223.
25. Hill AD, Tran KN, Akhurst T, et al. Lessons learned from 500 cases of lymphatic mapping for breast cancer. Ann Surg 1999;229:528.
26. Orr RK, Hoehn JL, Col NF. The learning curve for sentinel node biopsy in breast cancer: Practical considerations. Arch Surg 1999;134:764.
27. Goldhirsch A, Glick JH, Gelber RD, et al. Meeting highlights: International consensus panel on the treatment of primary breast cancer. J Clin Oncol 2001;18:3817.
28. Olmos VRA, Hoefnagel CA, Nieweg OE, et al. Lymphoscintigraphy in oncology: A rediscovered challenge. Ear J Nucl Med 1999;26:S2.
29. Tafra L. The learning curve and sentinel node biopsy. Am J Surg 2001;182:347.
30. Clare SE, Sener SF, Wilkens W, et al. Prognostic significance of occult lymph node metastases in breast cancer. Ann Surg Oncol 1997;4:447.
31. Tabar I, Fagerberg G, Chen HH, et al. Tumor development, histology, and grade of breast cancers: Prognosis and progression. Int J Cancer 1996;66:413.